SCHEMBL2710179

SCHEMBL2710179

COc1cc(F)c(-c2c3ccc(F)cc3c(-c3ccc(F)cc3F)c3c(F)c(F)c(F)c(F)c23)c(F)c1

nearest known ligand 0.37

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
AMY1A P0DUB6 1/20 0.36
MAPK14 Q16539 5/20 0.33
TRPA1 O75762 2/20 0.33
F2RL3 Q96RI0 1/20 0.33
NPC1 O15118 4/20 0.32
RAB9A P51151 4/20 0.32
SMN1; SMN2 Q16637 3/20 0.32
NQO2 P16083 1/20 0.31
GAA P10253 1/20 0.31
NFE2L2 Q16236 1/20 0.31
MAP2K4 P45985 1/20 0.30
PMM2 O15305 2/20 0.30
MIF P14174 2/20 0.30
MPI P34949 2/20 0.30
PHOSPHO1 Q8TCT1 2/20 0.30
APOBEC3G Q9HC16 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12086155 1.00 AMY1A (0.36) AMY1AMAPK14TRPA1F2RL3NPC1
SCHEMBL2709302 0.92 AMY1A (0.36) AMY1AMAPK14F2RL3NPC1RAB9A
SCHEMBL2936476 0.92 NQO2 (0.36) AMY1AMAPK14TRPA1NPC1RAB9A
SCHEMBL12086192 0.91 AMY1A (0.37) AMY1AMAPK14TRPA1F2RL3NPC1
SCHEMBL2724990 0.91 AMY1A (0.37) AMY1AMAPK14TRPA1F2RL3NPC1
SCHEMBL2942680 0.89 NQO2 (0.34) AMY1AMAPK14TRPA1NPC1RAB9A
SCHEMBL2724538 0.88 AMY1A (0.40) AMY1AMAPK14F2RL3NPC1RAB9A
SCHEMBL2942794 0.86 MAOB (0.33) AMY1AMAPK14TRPA1NPC1RAB9A
SCHEMBL12086217 0.86 ALDH1A1 (0.39) AMY1AMAPK14TRPA1NPC1RAB9A
SCHEMBL2728236 0.86 ALDH1A1 (0.39) AMY1AMAPK14TRPA1NPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2445987-B1 BLUE/VIOLET DIPHENYLANTHRACENE CHEMILUMINESCENT FLUORESCERS CYALUME TECH INC (US) 2018-05-02 EP disclosed
US-8257620-B2 Blue/violet diphenylanthracene chemiluminescent fluorescers CYALUME TECHNOLOGIES, INC. (US) 2012-09-04 US disclosed
EP-2445987-A1 BLUE/VIOLET DIPHENYLANTHRACENE CHEMILUMINESCENT FLUORESCERS Cyalume Technologies, Inc (US) 2012-05-02 EP disclosed
US-20100327240-A1 Blue/violet diphenylanthracene chemiluminescent fluorescers CYALUME TECHNOLOGIES, INC. 2010-12-30 US disclosed
WO-2010151654-A1 BLUE/VIOLET DIPHENYLANTHRACENE CHEMILUMINESCENT FLUORESCERS CYALUME TECHNOLOGIES, INC. (US) 2010-12-29 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100327240-A1 Blue/violet diphenylanthracene chemiluminescent fluorescers CYP2F1, FLAD1, AFF1 AMY1A 401/4885MAPK14 3742/4885TRPA1 2295/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.